Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2761291 | 1.00 | KDM4E (0.50) | KDM4EGGPS1FDPSNR5A1LMNA | |
| SCHEMBL2760858 | 1.00 | KDM4E (0.50) | KDM4EGGPS1FDPSNR5A1LMNA | |
| SCHEMBL2761016 | 1.00 | KDM4E (0.50) | KDM4EGGPS1FDPSNR5A1LMNA | |
| SCHEMBL2761243 | 1.00 | KDM4E (0.50) | KDM4EGGPS1FDPSNR5A1LMNA | |
| Hydrochloric Acid SCHEMBL2761023 | 0.98 | KDM4E (0.49) | KDM4EGGPS1FDPSNR5A1LMNA | |
| Hydrochloric Acid SCHEMBL2761038 | 0.98 | KDM4E (0.49) | KDM4EGGPS1FDPSNR5A1LMNA | |
| SCHEMBL2760994 | 0.94 | KDM4E (0.49) | KDM4EGGPS1FDPSNR5A1LMNA | |
| SCHEMBL6115387 | 0.87 | KDM4E (0.47) | KDM4EGGPS1FDPSALDH1A1LTA4H | |
| Hydrochloric Acid SCHEMBL2761537 | 0.86 | KDM4E (0.46) | KDM4EGGPS1FDPSHSP90AA1ALDH1A1 | |
| SCHEMBL1512933 | 0.79 | HSP90AA1 (0.49) | GGPS1FDPSLMNAHSP90AA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140322351-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2014-10-30 | — | — | US | claimed |
| US-20110311647-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2011-12-22 | — | — | US | claimed |
| EP-2389071-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | Kane Biotech Inc. (CA) | 2011-11-30 | — | — | EP | claimed |
| WO-2010083589-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2010-07-29 | — | — | WO | claimed |
| US-9622481-B2 | Biofilm-removing antimicrobial compositions and uses thereof | KANE BIOTECH INC. (CA) | 2017-04-18 | — | — | US | disclosed |
| US-20140322351-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2014-10-30 | — | — | US | disclosed |
| US-8753692-B2 | Biofilm-removing antimicrobial compositions and uses thereof | KANE BIOTECH INC. (CA) | 2014-06-17 | — | — | US | disclosed |
| US-20130203602-A1 | SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2013-08-08 | — | — | US | disclosed |
| EP-2544664-A1 | SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS | Danmarks Tekniske Universitet (DK) | 2013-01-16 | — | — | EP | disclosed |
| US-20110311647-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-2389071-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | Kane Biotech Inc. (CA) | 2011-11-30 | — | — | EP | disclosed |
| WO-2011110662-A1 | SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2011-09-15 | — | — | WO | disclosed |
| WO-2010083589-A1 | BIOFILM-REMOVING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | KANE BIOTECH INC. (CA) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130203602-A1 | SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS | MIF, BMP2, BMP4 | KDM4E 3887/4885GGPS1 1877/4885FDPS 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.